PortfoliosLab logoPortfoliosLab logo
INVA vs. UAMY
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

INVA vs. UAMY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Innoviva, Inc. (INVA) and United States Antimony Corporation (UAMY). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

INVA vs. UAMY - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
INVA
Innoviva, Inc.
17.11%15.22%8.17%21.06%-23.19%39.23%-12.50%-18.85%22.97%32.62%
UAMY
United States Antimony Corporation
65.34%183.62%610.84%-48.86%-2.19%-4.64%35.58%-33.62%81.25%27.49%

Fundamentals

Market Cap

INVA:

$2.00B

UAMY:

$1.03B

EPS

INVA:

$3.19

UAMY:

-$0.03

PS Ratio

INVA:

4.83

UAMY:

26.38

PB Ratio

INVA:

1.70

UAMY:

7.28

Total Revenue (TTM)

INVA:

$411.33M

UAMY:

$39.26M

Gross Profit (TTM)

INVA:

$307.67M

UAMY:

$9.87M

EBITDA (TTM)

INVA:

$203.88M

UAMY:

-$6.89M

Returns By Period

In the year-to-date period, INVA achieves a 17.11% return, which is significantly lower than UAMY's 65.34% return. Over the past 10 years, INVA has underperformed UAMY with an annualized return of 6.20%, while UAMY has yielded a comparatively higher 42.52% annualized return.


INVA

1D
0.47%
1M
2.54%
YTD
17.11%
6M
28.84%
1Y
30.49%
3Y*
27.67%
5Y*
14.38%
10Y*
6.20%

UAMY

1D
-4.93%
1M
-22.07%
YTD
65.34%
6M
9.93%
1Y
268.89%
3Y*
180.17%
5Y*
47.47%
10Y*
42.52%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

INVA vs. UAMY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

INVA
INVA Risk / Return Rank: 7171
Overall Rank
INVA Sharpe Ratio Rank: 7575
Sharpe Ratio Rank
INVA Sortino Ratio Rank: 7676
Sortino Ratio Rank
INVA Omega Ratio Rank: 7070
Omega Ratio Rank
INVA Calmar Ratio Rank: 6666
Calmar Ratio Rank
INVA Martin Ratio Rank: 6666
Martin Ratio Rank

UAMY
UAMY Risk / Return Rank: 8686
Overall Rank
UAMY Sharpe Ratio Rank: 9090
Sharpe Ratio Rank
UAMY Sortino Ratio Rank: 8888
Sortino Ratio Rank
UAMY Omega Ratio Rank: 8282
Omega Ratio Rank
UAMY Calmar Ratio Rank: 8989
Calmar Ratio Rank
UAMY Martin Ratio Rank: 8383
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

INVA vs. UAMY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Innoviva, Inc. (INVA) and United States Antimony Corporation (UAMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


INVAUAMYDifference

Sharpe ratio

Return per unit of total volatility

1.09

2.06

-0.97

Sortino ratio

Return per unit of downside risk

1.96

2.71

-0.75

Omega ratio

Gain probability vs. loss probability

1.23

1.31

-0.09

Calmar ratio

Return relative to maximum drawdown

1.24

3.73

-2.49

Martin ratio

Return relative to average drawdown

2.96

6.95

-3.99

INVA vs. UAMY - Sharpe Ratio Comparison

The current INVA Sharpe Ratio is 1.09, which is lower than the UAMY Sharpe Ratio of 2.06. The chart below compares the historical Sharpe Ratios of INVA and UAMY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


INVAUAMYDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.09

2.06

-0.97

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.52

0.51

+0.01

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.18

0.43

-0.24

Sharpe Ratio (All Time)

Calculated using the full available price history

0.06

0.07

-0.01

Correlation

The correlation between INVA and UAMY is 0.06, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

INVA vs. UAMY - Dividend Comparison

Neither INVA nor UAMY has paid dividends to shareholders.


TTM20252024202320222021202020192018201720162015
INVA
Innoviva, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%7.12%
UAMY
United States Antimony Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

INVA vs. UAMY - Drawdown Comparison

The maximum INVA drawdown since its inception was -84.32%, smaller than the maximum UAMY drawdown of -96.44%. Use the drawdown chart below to compare losses from any high point for INVA and UAMY.


Loading graphics...

Drawdown Indicators


INVAUAMYDifference

Max Drawdown

Largest peak-to-trough decline

-84.32%

-96.44%

+12.12%

Max Drawdown (1Y)

Largest decline over 1 year

-23.53%

-74.30%

+50.77%

Max Drawdown (5Y)

Largest decline over 5 years

-47.01%

-84.49%

+37.48%

Max Drawdown (10Y)

Largest decline over 10 years

-59.57%

-89.76%

+30.19%

Current Drawdown

Current decline from peak

-26.80%

-52.49%

+25.69%

Average Drawdown

Average peak-to-trough decline

-44.79%

-66.57%

+21.78%

Ulcer Index

Depth and duration of drawdowns from previous peaks

9.85%

39.90%

-30.05%

Volatility

INVA vs. UAMY - Volatility Comparison

The current volatility for Innoviva, Inc. (INVA) is 6.02%, while United States Antimony Corporation (UAMY) has a volatility of 39.33%. This indicates that INVA experiences smaller price fluctuations and is considered to be less risky than UAMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


INVAUAMYDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.02%

39.33%

-33.31%

Volatility (6M)

Calculated over the trailing 6-month period

21.63%

107.41%

-85.78%

Volatility (1Y)

Calculated over the trailing 1-year period

28.15%

131.56%

-103.41%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

27.88%

93.61%

-65.73%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

34.05%

100.36%

-66.31%

Financials

INVA vs. UAMY - Financials Comparison

This section allows you to compare key financial metrics between Innoviva, Inc. and United States Antimony Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00M40.00M60.00M80.00M100.00M120.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
114.61M
13.03M
(INVA) Total Revenue
(UAMY) Total Revenue
Values in USD except per share items